Abstract : HLA-B27 associated uveitis is characterized by recurrent alternating acute unilateral attacks of intraocular inflammation in the anterior chamber. The aim of this study was to report an unusual case of repeated exacerbations with vitreous hemorrhage in HLA-B27 associated uveitis. Thirty four-year-old man was diagnosed as HLA-B27 associated uveitis in his right eye. He showed repeated exacerbation of ocular inflammation with retinal vein dilation and small retinal hemorrhage following vitreous hemorrhage. Fluorescein fundus angiography a week before the appearance of vitreous hemorrhage showed no neovascularization. Oral prednisolone administration was started from 40 mg/day with gradual tapering. About 3 weeks after the onset, most of the vitreous hemorrhage disappeared and visual acuity was improved to 20/20. Through the decreased vitreous hemorrhage, Weiss ring was detected later. The vitreous hemorrhage found in this patient is a severe exacerbation, and might be a consequence of the vitritis that leads to posterior vitreous detachment.
INTRODUCTION
HLA-B27 associated uveitis is characterized by recurrent alternating acute unilateral attacks of intraocular inflammation in the anterior chamber (1, 2) , and the intervals of them are a half year to several years. On the other hand, the reported frequencies of posterior segment involvement in HLA-B27 associated uveitis rage between 0 to 25.1% (1, (3) (4) (5) . The involvement was recognized as vitritis, cystoid macular edema, or papillitis. Treatment of HLA-B27 associated uveitis is mainly topical corticosteroids and mydriatic agents, while systemic corticosteroid administration is required in 24% of the patients to control the inflammations (5).
Here we report a case of HLA-B27 associated uveitis that showed repeated exacerbations and developed retinal and vitreous hemorrhages.
CASE REPORT
A 34-year-old man suffered from blurred vision and ocular pain in his right eye, and was treated with topical and systemic corticosteroids. However, his symptoms did not improve, and then, he was referred 2 weeks later to our hospital on December 16, 2002. His visual acuities were 14/20 OD and 20/20 OS. Intraocular pressures were 16 mmHg OD, and 14 mmHg OS. Biomicroscopy showed remarkable ciliary injection and severe inflammation in the anterior chamber with 3+ flare and 3+ cells, fibrin production and hypopyon in the right eye. Almost 360 degrees of posterior synechiae and pigmentation on the lens were noted. Fundus examination showed no particular findings at that time. The left eye was normal. Peripheral blood test detected positive for HLA-B27. From these clinical and serological findings, we diagnosed the case as HLA-B27 associated uveitis OD. Other systemic diseases associated with HLA-B27 such as ankylosing spondylitis, inflammatory bowel diseases or Reiter's syndrome (6) were not remarkable. In addition to eye drops of mydriasis and betamethazone, oral prednisolone of 40 mg/day for 3 days and 30 mg/day for 3 days was administrated. Since intraocular inflammation improved and posterior synechiae were disolved, oral corticosteroid administration could be stopped. However, 1 week later, right fundus showed diffuse vitreous opacity and mild dilatation of retinal vessels (Fig. 1a) . He was given oral prednisolone again from 40 mg/day. Fundus findings gradually improved and oral prednisolone was decreased. Hence right visual acuity was recovered to 14/20 on January 16, 2003. Gradually, remained vitreous opacity resolved, and the inflammation in his right eye disappeared for 2 months. However, he complained of blurred vision in his right eye again. Although inflammation in the anterior segment was minimal, fundus examination showed obvious irregular dilatation of retinal vein and several small retinal hemorrhages as well as hyperemic optic disc in the posterior pole in the right eye on March 11, 2003 (Fig. 1b) . At that time although we performed fundus flurorescein angiography, leakage from vessels or neovascularization was not observed (Fig. 1c) . After a week, his visual acuity suddenly decreased to 2/200 in OD, and fundus examination showed vitreous hemorrhage (Fig. 1d) . In addition to topical corticosteroids, oral prednisolone was administrated again from 40 mg/day and was gradually decreased. 
DISCUSSION
HLA-B27 associated uveitis is characterized by younger age at onset, high male to female ratio, frequent unilateral altering eye involvement, severe ocular symptom during activity such as presence of fibrin in the anterior chamber (1). D'Alessandro, et al. demonstrated that HLA-B27 associated uveitis was the most common cause of hypopyon uveitis (7) . Taken together, intraocular inflammation of this case showed at first visit to our hospital was consistent with previous reports in HLA-B27 associated uveitis.
HLA-B27 associated uveitis is one of the common forms in intraocular inflammation showing acute anterior uveitis (AAU) (8, 9) . Recently, it is reported that the frequencies of posterior segment involvement in the uveitis rage between 0 to 25.1% (3, 5, 10, 11) . It is reported that the involvement of posterior segment is recognized as vitritis, cystoid macular edema, papillitis and retinal vasculitis (5, 12) and it is suggested to occur secondary to anterior segment intraocular inflammation (3) . In this case after improvement of AAU, diffuse vitreous opacity and retinal vessel dilatation, and moreover retinal and vitreous hemorrhage were noted.
Vitreous hemorrhage is extravasated blood within the space bordered by the internal limiting membrane of the retina (13) . Posterior vitreous detachment (PVD) is one of the common causes of vitreous hemorrhage (13) . Weiss ring is a circular retinal grial adhesion to the optic disc, which has close association with PVD (14) . In our case, before the onset of vitreous hemorrhage, right fundus showed prominent retinal vein dilatation and retinal hemorrhage, suggesting that severe exacerbation of inflammation occurred in the posterior segment. In addition, Weiss ring was detected through the vitreous hemorrhage, indicating PVD had constituted in exacerbation of inflammation. These clinical courses might have been correlated with onset of vitreous hemorrhage.
Usually recurrence happens after the intervals about a half to several years, and it must start with acute inflammation of the anterior segment. The inflammations observed during the treatments in our case involved minimal inflammations of anterior segment and severe inflammation of posterior segment such as retinal vein dilatation, retinal hemorrhage, and hyperemic optic disc. This suggests that the repeated inflammations during the treatments in this case were exacerbation, but not recurrence. Treatment of HLA-B27 associated uveitis generally involves topical application of corticosteroid preparations to control the inflammation, and the treatment is generally effective. However, some patients with HLA-B27 associated uveitis are difficult to treat, and require systemic corticosteroid administration. In this case, systemic corticosteroid administrations were needed and repeated exacerbations occurred. Although this is not typical case of HLA-B27 associated uveitis, we should pay attention to the fact that severe exacerbation can occur even after resolving inflammation in HLA-B27 associated uveitis.
